[{"orgOrder":0,"company":"SBPharmaceutical IND, Co., LTD","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Antimony","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"SBPharmaceutical IND, Co., LTD","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"SBPharmaceutical IND, Co., LTD \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"SBPharmaceutical IND, Co., LTD \/ Undisclosed"},{"orgOrder":0,"company":"SBPharmaceutical IND, Co., LTD","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Antimony","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"SBPharmaceutical IND, Co., LTD","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"SBPharmaceutical IND, Co., LTD \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"SBPharmaceutical IND, Co., LTD \/ Undisclosed"},{"orgOrder":0,"company":"SBPharmaceutical IND, Co., LTD","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Antimony","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"SBPharmaceutical IND, Co., LTD","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"SBPharmaceutical IND, Co., LTD \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"SBPharmaceutical IND, Co., LTD \/ Undisclosed"},{"orgOrder":0,"company":"SBPharmaceutical IND, Co., LTD","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Antimony","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"SBPharmaceutical IND, Co., LTD","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"SBPharmaceutical IND, Co., LTD \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"SBPharmaceutical IND, Co., LTD \/ Undisclosed"}]
Find Clinical Drug Pipeline Developments & Deals for Antimony
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
